SABATOLIMAB

UNII:	3L7R886Y06
Formula:
Preferred Substance Name:	SABATOLIMAB

2252262-24-9
ANTI-TIM3 CHECKPOINT INHIBITOR MBG453
ANTI-TIM-3 MONOCLONAL ANTIBODY MBG453
IMMUNOGLOBULIN G4 (226-PROLINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN HEPATITIS VIRUS A CELLULAR RECEPTOR 2) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS HAVCR2 (HEPATITIS A VIRUS CELLULAR RECEPTOR 2, T-CELL IMMUNOGLOBULIN MUCIN FAMILY MEMBER 3, TIM-3, TIM3, TIMD3, CD366)), HUMANIZED MONOCLONAL ANTIBODY
MBG453
MBG-453
NVP-MBG453
SABATOLIMAB [INN]
SABATOLIMAB [JAN]
SABATOLIMAB [USAN]
SABATOLIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SABATOLIMAB

Synonyms and Mappings

Resources